HIF-1α has been reported to upregulate KDM5C, which mediates methylation of genes related to inflammation, stem cell differentiation, and hypoxia response, suggesting KDM5C’s potential involvement in the hypoxic tumor microenvironment and as a therapeutic target [223]. This evidence concerns the gene HIF1A and neoplasm.